Correlation Between Heidelberg Pharma and CanSino Biologics

Can any of the company-specific risk be diversified away by investing in both Heidelberg Pharma and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Heidelberg Pharma and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Heidelberg Pharma AG and CanSino Biologics, you can compare the effects of market volatilities on Heidelberg Pharma and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Heidelberg Pharma with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Heidelberg Pharma and CanSino Biologics.

Diversification Opportunities for Heidelberg Pharma and CanSino Biologics

-0.48

Correlation Coefficient

Heidelberg Pharma  CanSino Biologics

Very good diversification

The 3 months correlation between Heidelberg and CanSino is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Heidelberg Pharma AG and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Heidelberg Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Heidelberg Pharma AG are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Heidelberg Pharma i.e., Heidelberg Pharma and CanSino Biologics go up and down completely randomly.

Pair Corralation between Heidelberg Pharma and CanSino Biologics

Assuming the 90 days trading horizon Heidelberg Pharma AG is expected to under-perform the CanSino Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Heidelberg Pharma AG is 1.77 times less risky than CanSino Biologics. The stock trades about -0.01 of its potential returns per unit of risk. The CanSino Biologics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  302.00  in CanSino Biologics on October 25, 2024 and sell it today you would earn a total of  40.00  from holding CanSino Biologics or generate 13.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Heidelberg Pharma AG  vs.  CanSino Biologics

Heidelberg Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Heidelberg Pharma AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Heidelberg Pharma is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

CanSino Biologics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CanSino Biologics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Heidelberg Pharma and CanSino Biologics

The main advantage of trading using opposite Heidelberg Pharma and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Heidelberg Pharma position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.

The idea behind Heidelberg Pharma AG and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.